Testosterone implants added to MIMS

Testosterone implants now listed in MIMS | SPL
Testosterone implants now listed in MIMS | SPL

Testosterone subcutaneous implants are now listed in MIMS.

The 100mg and 200mg implants are indicated for primary and secondary hypogonadism in males. Implants should be inserted into an area where there is relatively little movement or blood supply, such as the lower abdominal wall or buttock.

The recommended dose is 100-600mg. In most hypogonadal men a dose of 600mg maintains plasma testosterone levels within the normal physiological range for 4–5 months.

View Testosterone Implant drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Flu antivirals approved for NHS prescribing as cases increase

Flu antivirals approved for NHS prescribing as cases increase

GPs can now prescribe antiviral medicines for flu prophylaxis...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

New e-cigarette alternative launched on prescription

New e-cigarette alternative launched on prescription

Voke, a new nicotine inhaler, is available to prescribe...

Smoking Cessation Treatment Options

Smoking Cessation Treatment Options

Types and suitabilities of smoking cessation treatments.